Clinical Access Advancement: Evaluation of NOSES Technology in High-Risk Colorectal Oncology

As the global aging population increases, the safety and recovery speed of surgical interventions for oncology patients with cardiovascular comorbidities have become core metrics of clinical excellence. The recent completion of the first Natural Orifice Specimen Extraction Surgery (NOSES) for colorectal cancer at Beijing Tiantan Hospital exemplifies this evolution.

In this case, a Multidisciplinary Team (MDT) designed a tailored protocol for an elderly patient with a history of cardiac ablation. The core technical advantages of the NOSES approach include:

1. Biomechanical Integrity: The total elimination of the 5cm auxiliary abdominal incision prevents incisional hernias and preserves abdominal wall function.
2. Stress Response Mitigation: The ultra-minimal access significantly reduces perioperative pain and pharmacological requirements, minimizing the impact on the cardiovascular system.
3. Enhanced Recovery After Surgery (ERAS): The patient achieved ambulation and oral intake within 24 hours, with a total hospital stay reduced by over 30% compared to conventional laparoscopy.

As a professional medical facilitation agency, we continuously monitor the clinical benchmarks of such sophisticated modalities. The integration of neurology and general surgery expertise at Tiantan Hospital provides a unique safety net for managing oncological patients with complex systemic risks. Our mission is to align these "high-precision, low-morbidity" clinical paths with appropriate global patients, shifting the paradigm of gastrointestinal cancer treatment toward high-quality, long-term survival.